Literature DB >> 19838490

Predictors of hospital mortality in hemodynamically stable patients with pulmonary embolism.

André Volschan1, Denilson Albuquerque, Bernardo Rangel Tura, Marcos Knibel, José Péricles Esteves, Luiz Carlos Bodanese, Francisco Silveira, João Pantoja, Paulo Cesar Pereira da Silva e Souza, João Mansur, Evandro Tinoco Mesquita.   

Abstract

BACKGROUND: Pulmonary embolism is associated with high mortality in patients with hypotension or circulatory shock. However, the association between some clinical variables and mortality is still unclear in hemodynamically stable patients.
OBJECTIVES: To derive an in-hospital mortality risk stratification model in hemodynamically stable patients with pulmonary embolism.
METHODS: This is a prospective multicenter cohort study of 582 consecutive patients admitted in emergency units or intensive care units with clinically suspected pulmonary embolism and whose diagnosis was confirmed by one or more of the following tests: pulmonary arteriography, spiral CT angiography, magnetic resonance angiography, Doppler echocardiography, pulmonary scintigraphy, or venous duplex scan. Data on demographics, comorbidities and clinical manifestations were collected and included in a logistic regression analysis so as to build the prediction model.
RESULTS: Overall mortality was 14.1%. The following parameters were identified as independent death risk variables: age > 65 years, bed rest > 72h, chronic cor pulmonale, sinus tachycardia, and tachypnea. After risk stratification, mortalities of 5.4%, 17.8%, and 31.3% were found in the low, moderate and high-risk subgroups, respectively. The model showed 65.5% sensitivity and 80% specificity, with a 0.77 area under the curve.
CONCLUSION: In hemodynamically stable patients with pulmonary embolism, age > 65 years, bed rest > 72h, chronic cor pulmonale, sinus tachycardia and tachypnea were independent predictors of in-hospital mortality. However, further validation of the prediction model in other populations is required so that it can be incorporated into the clinical practice.

Entities:  

Mesh:

Year:  2009        PMID: 19838490     DOI: 10.1590/s0066-782x2009000800011

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  6 in total

1.  Inhospital mortality among clinical and surgical inpatients recently diagnosed with venous thromboembolic disease.

Authors:  María Lourdes Posadas-Martínez; Fernando Javier Vázquez; María Florencia Grande-Ratti; Fernán González Bernaldo de Quirós; Diego Hernán Giunta
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

2.  Severe hypoxaemia can predict unfavourable clinical outcomes in individuals with pulmonary embolism aged over 40 years.

Authors:  Caio Simoes Souza; Fernanda Simoes Seabra Resende; Marcelo Palmeira Rodrigues
Journal:  Singapore Med J       Date:  2014-09       Impact factor: 1.858

Review 3.  Venous thromboembolism in Latin America: a review and guide to diagnosis and treatment for primary care.

Authors:  Jose Manuel Ceresetto
Journal:  Clinics (Sao Paulo)       Date:  2016-01       Impact factor: 2.365

Review 4.  Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis.

Authors:  Antoine Elias; Susan Mallett; Marie Daoud-Elias; Jean-Noël Poggi; Mike Clarke
Journal:  BMJ Open       Date:  2016-04-29       Impact factor: 2.692

5.  Prognostic value of lactates in relation to gas analysis and acid-base status in patients with pulmonary embolism.

Authors:  Kristina Galić; Danijel Pravdić; Zrinko Prskalo; Suzana Kukulj; Boris Starčević; Mladenka Vukojević
Journal:  Croat Med J       Date:  2018-08-31       Impact factor: 1.351

6.  Pulmonary embolism in chronic kidney disease and end-stage renal disease hospitalizations: Trends, outcomes, and predictors of mortality in the United States.

Authors:  Jagmeet Singh; Sushmita Khadka; Dhanshree Solanki; Asim Kichloo; Harshil Shah; Manasee J Vyas; Savneek Chugh; Neil Patel; Shantanu Solanki
Journal:  SAGE Open Med       Date:  2021-06-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.